Insider Transactions in Q1 2023 at Myriad Genetics Inc (MYGN)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 27
2023
|
Nicole Lambert Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
6,433
-2.61%
|
$147,959
$23.48 P/Share
|
|
Mar 25
2023
|
Natalie Munk Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
365
-1.2%
|
$8,395
$23.72 P/Share
|
|
Mar 24
2023
|
Paul J Diaz President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
45,425
-1.81%
|
$1,044,775
$23.72 P/Share
|
|
Mar 24
2023
|
Richard Bryan Riggsbee Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,929
-1.19%
|
$205,367
$23.72 P/Share
|
|
Mar 24
2023
|
Nicole Lambert Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,267
-1.05%
|
$121,141
$23.72 P/Share
|
|
Mar 24
2023
|
Mark Verratti Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,669
-0.5%
|
$61,387
$23.72 P/Share
|
|
Mar 24
2023
|
Kevin Richard Haas Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,816
-1.28%
|
$64,768
$23.72 P/Share
|
|
Mar 24
2023
|
Dale Muzzey Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
917
-0.66%
|
$21,091
$23.72 P/Share
|
|
Mar 24
2023
|
Natalie Munk Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
987
-1.63%
|
$22,701
$23.72 P/Share
|
|
Mar 22
2023
|
Dale Muzzey Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,399
-1.97%
|
$30,778
$22.91 P/Share
|
|
Mar 22
2023
|
Margaret Ancona SVP, Chief of Staff |
SELL
Payment of exercise price or tax liability
|
Direct |
751
-1.47%
|
$16,522
$22.91 P/Share
|
|
Mar 22
2023
|
Natalie Munk Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
388
-1.24%
|
$8,536
$22.91 P/Share
|
|
Mar 22
2023
|
Paul J Diaz President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
20,046
-1.56%
|
$441,012
$22.91 P/Share
|
|
Mar 22
2023
|
Richard Bryan Riggsbee Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,074
-1.07%
|
$89,628
$22.91 P/Share
|
|
Mar 22
2023
|
Nicole Lambert Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,419
-0.95%
|
$53,218
$22.91 P/Share
|
|
Mar 22
2023
|
Mark Verratti Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,351
-0.51%
|
$29,722
$22.91 P/Share
|
|
Mar 22
2023
|
Kevin Richard Haas Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,677
-1.49%
|
$36,894
$22.91 P/Share
|
|
Mar 22
2023
|
Pamela Wong Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,432
-1.94%
|
$31,504
$22.91 P/Share
|
|
Mar 15
2023
|
Natalie Munk Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,000
+16.14%
|
-
|
|
Mar 15
2023
|
Kevin Richard Haas Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
28,459
+20.16%
|
-
|
|
Mar 15
2023
|
Dale Muzzey Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
28,459
+28.56%
|
-
|
|
Mar 15
2023
|
Paul J Diaz President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
197,023
+13.3%
|
-
|
|
Mar 15
2023
|
Nicole Lambert Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
39,405
+13.4%
|
-
|
|
Mar 15
2023
|
Richard Bryan Riggsbee Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
43,783
+10.29%
|
-
|
|
Mar 15
2023
|
Pamela Wong Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,892
+22.89%
|
-
|
|
Mar 15
2023
|
Margaret Ancona SVP, Chief of Staff |
BUY
Grant, award, or other acquisition
|
Direct |
16,419
+24.35%
|
-
|
|
Mar 15
2023
|
Mark Verratti Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
39,405
+12.84%
|
-
|
|
Mar 02
2023
|
Richard Bryan Riggsbee Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
15,000
-4.25%
|
$330,000
$22.55 P/Share
|
|
Mar 02
2023
|
Nicole Lambert Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
13,184
-5.77%
|
$290,048
$22.74 P/Share
|
|
Mar 01
2023
|
Shereen Solaiman Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
15,856
+50.0%
|
-
|
|
Feb 25
2023
|
Margaret Ancona SVP, Chief of Staff |
SELL
Payment of exercise price or tax liability
|
Direct |
2,556
-6.88%
|
$46,008
$18.54 P/Share
|
|
Feb 25
2023
|
Kevin Richard Haas Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,012
-1.19%
|
$18,216
$18.54 P/Share
|
|
Feb 18
2023
|
Richard Bryan Riggsbee Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
11,222
-3.08%
|
$213,218
$19.42 P/Share
|
|
Jan 20
2023
|
Richard Bryan Riggsbee Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
9,400
-2.52%
|
$188,000
$20.04 P/Share
|
|
Jan 18
2023
|
Richard Bryan Riggsbee Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
600
-0.16%
|
$12,000
$20.01 P/Share
|
|
Jan 01
2023
|
Nicole Lambert Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
853
-0.37%
|
$11,942
$14.51 P/Share
|
|
Jan 01
2023
|
Dale Muzzey Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
302
-0.7%
|
$4,228
$14.51 P/Share
|